We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Feather Safety Razor

Stryker Worldwide

evelops medical products and technologies, including Implants (joint replacement), Trauma, Craniomaxillofacial, Spina... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
26 Oct 2021 - 28 Oct 2021
Virtual Venue

Stryker Completes Acquisition of Medical Device Company Gauss Surgical

By HospiMedica International staff writers
Posted on 09 Sep 2021
Print article
Illustration
Illustration
Stryker (Kalamazoo, MI, USA) has completed the acquisition of Gauss Surgical (Menlo Park, CA, USA), a medical device company that has developed Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery.

Up to 5% of mothers will experience a post-partum hemorrhage, which is the leading cause of maternal death globally. Studies suggest that 70% of these are preventable. Prevention, early recognition and timely treatment of maternal hemorrhage have the highest impact on decreasing maternal complications. Triton has demonstrated improvements in maternal and surgical care through earlier recognition of hemorrhage leading to earlier intervention.

"Gauss Surgical's innovative Triton technology will help fill the void of quantifying blood loss to enable accuracy, early detection of hemorrhage and prevention of maternal morbidity," said Dylan Crotty, President of Stryker's Instruments division. "Our belief is that Triton technology will help improve the industry standards for quantifying blood loss in the labor and delivery department, furthering Stryker's commitment to improve safety and outcomes for our caregivers and their patients."

"Since the advent of modern surgery, visual estimation of blood loss has remained a notoriously inaccurate and imprecise standard of care," said Siddarth Satish, CEO and Founder of Gauss Surgical. "I am excited to expand this offering with Stryker."

Related Links:
Stryker
Gauss Surgical



Print article

Channels

Copyright © 2000-2021 Globetech Media. All rights reserved.